Skip to content

Clinical trials

Completed Phase 2/3 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Completed Country / region: China Clear all

210 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20063
20072
20087
200915
20107
201116
201210
201311
201410
201512
201615
201716
201814
201910
202010
202111
202215
202314
20249
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed210

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong9
Fudan University9
Beijing Tiantan Hospital7
Fuda Cancer Hospital, Guangzhou7
Nanfang Hospital, Southern Medical University7
Shanghai Jiao Tong University School of Medicine6
The University of Hong Kong6
Chengdu University of Traditional Chinese Medicine5
Chinese Academy of Sciences5
Hebei Medical University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung8
Ischemic Stroke8
Breast Neoplasms4
Carcinoma, Hepatocellular4
Colorectal Neoplasms4
Metabolic Syndrome4
Neoplasms4
Stomach Neoplasms4
Stroke4
Arthritis, Rheumatoid3

Trials

Showing 1 to 25 of 210. Each trial links to its page on Pharma Observatory.

110 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.